Brown-Séquard testicular extract (organotherapy)
injection · 1889–1894
SHORT PITCH (AS SOLD)
Subcutaneous injection of aqueous extract from animal testes, claimed to restore physical and mental vigor in older men.
THE ACTUAL EVIDENCE
Modern reconstruction of the dose (Cussons et al, *Med J Aust* 2002) shows the testosterone delivered per injection was roughly four orders of magnitude below any therapeutic level. The aqueous extraction method does not concentrate testosterone meaningfully; the active hormone identified later as the principal androgen of testicular tissue is present in fresh testes at levels that, after Brown-Séquard's preparation method, would yield essentially no biologically active dose. Reported clinical effects in Brown-Séquard's own report and in the subsequent commercial literature are attributable to placebo response.
PRACTITIONERS
INGREDIENTS
CASES
CLAIMS
- Subcutaneous injection of aqueous extract from animal testes restores physical strength, mental acuity, and general functional capacity in older men through exogenous supplementation of a 'vital substance' secreted by the testes. refuted
- The testicular-extract protocol reverses the effects of aging in elderly recipients, restoring functional capacities of younger age and extending productive years. refuted
- The testicular-extract injection protocol is safe; the preparation does not produce significant adverse reactions and the procedure presents no meaningful health risk to the recipient. refuted
SOURCES
- Effets produits chez l'homme par des injections sous-cutanées d'un liquide retiré des testicules frais de cobaye et de chien (1889)
- The effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals (1889)
- Brown-Séquard revisited: a lesson from history on the placebo effect of androgen treatment (2002)
NOTES
Brown-Séquard’s testicular extract was the founding intervention of modern elite-targeted rejuvenation medicine. The protocol was developed and announced by a senior academic physiologist in 1889 and was being sold commercially across Europe and North America within a year. The preparation method (crude aqueous extraction of fresh animal testes) delivered no biologically meaningful dose of the active hormone later identified; reported effects were necessarily a placebo response. The intervention is the direct intellectual ancestor of testosterone replacement therapy, peptide protocols, and the broader category of hormonal and biological-substance-replacement interventions sold to older men on the premise of restored vigor.